CymaBay Therapeutics (CBAY) Misses Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts CBAY Hot Sheet
Join SI Premium – FREE
CymaBay Therapeutics (NASDAQ: CBAY) reported Q3 EPS of ($0.32), $0.03 worse than the analyst estimate of ($0.29).
For earnings history and earnings-related data on CymaBay Therapeutics (CBAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank cuts Novo Nordisk to Sell after earnings, shares dip
- Lucky Strike Entertainment Corporation (LUCK) reported Q2 Revenue ; Offers Guidance
- Titan Machinery (TITN) Misses Q2 EPS by 5c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
